{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:36:18Z","timestamp":1790120178393,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Shanghai Health Commission Research Project","award":["201840199"],"award-info":[{"award-number":["201840199"]}]},{"name":"Shanghai Science and Technology Commission Research Project","award":["18ZR1435700"],"award-info":[{"award-number":["18ZR1435700"]}]},{"name":"Excellent Discipline Leader Cultivation Program of Shanghai","award":["GWV-10.2-XD09"],"award-info":[{"award-number":["GWV-10.2-XD09"]}]},{"name":"Three-year Action Program of Public Health","award":["GWV-9.1"],"award-info":[{"award-number":["GWV-9.1"]}]},{"name":"National Key R&D Program","award":["2021YFC2702100"],"award-info":[{"award-number":["2021YFC2702100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s40123-023-00755-4","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T13:01:50Z","timestamp":1688562110000},"page":"2557-2568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study"],"prefix":"10.1007","volume":"12","author":[{"given":"Linlin","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliuxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7196-9340","authenticated-orcid":false,"given":"Mengjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"755_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","volume":"62","author":"IG Morgan","year":"2018","unstructured":"Morgan IG, French AN, Ashby RS, et\u00a0al. The epidemics of myopia: aetiology and prevention. Prog Retin Eye Res. 2018;62:134\u201349.","journal-title":"Prog Retin Eye Res"},{"issue":"9827","key":"755_CR2","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","volume":"379","author":"IG Morgan","year":"2012","unstructured":"Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012;379(9827):1739\u201348.","journal-title":"Lancet"},{"issue":"5","key":"755_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, et\u00a0al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036\u201342.","journal-title":"Ophthalmology"},{"issue":"5","key":"755_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1475-1313.2005.00298.x","volume":"25","author":"SM Saw","year":"2005","unstructured":"Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005;25(5):381\u201391.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"4","key":"755_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","volume":"123","author":"J Huang","year":"2016","unstructured":"Huang J, Wen D, Wang Q, et\u00a0al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology. 2016;123(4):697\u2013708.","journal-title":"Ophthalmology"},{"issue":"5","key":"755_CR6","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1167\/iovs.10-5485","volume":"52","author":"T Kakita","year":"2011","unstructured":"Kakita T, Hiraoka T, Oshika T. Influence of overnight orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci. 2011;52(5):2170\u20134.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"755_CR7","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077\u201385.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"755_CR8","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1167\/iovs.13-12527","volume":"54","author":"C Chen","year":"2013","unstructured":"Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci. 2013;54(10):6510\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"755_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","volume":"129","author":"A Ha","year":"2022","unstructured":"Ha A, Kim SJ, Shim SR, Kim YK, Jung JH. Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis. Ophthalmology. 2022;129(3):322\u201333.","journal-title":"Ophthalmology"},{"issue":"2","key":"755_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123(2):391\u20139.","journal-title":"Ophthalmology"},{"issue":"3","key":"755_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","volume":"129","author":"JC Yam","year":"2022","unstructured":"Yam JC, Zhang XJ, Zhang Y, et\u00a0al. Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report. Ophthalmology. 2022;129(3):308\u201321.","journal-title":"Ophthalmology"},{"issue":"11","key":"755_CR12","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1097\/OPX.0000000000000034","volume":"90","author":"J Santodomingo-Rubido","year":"2013","unstructured":"Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Guti\u00e9rrez-Ortega R. Factors preventing myopia progression with orthokeratology correction. Optom Vis Sci. 2013;90(11):1225\u201336.","journal-title":"Optom Vis Sci"},{"issue":"8","key":"755_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","volume":"128","author":"FF Li","year":"2021","unstructured":"Li FF, Zhang Y, Zhang X, et\u00a0al. Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: low-concentration atropine for myopia progression study. Ophthalmology. 2021;128(8):1180\u20137.","journal-title":"Ophthalmology"},{"issue":"1","key":"755_CR14","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.1038\/s41598-020-69710-8","volume":"10","author":"N Kinoshita","year":"2020","unstructured":"Kinoshita N, Konno Y, Hamada N, et\u00a0al. Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial. Sci Rep. 2020;10(1):12750.","journal-title":"Sci Rep"},{"issue":"5","key":"755_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/opo.12722","volume":"40","author":"Q Tan","year":"2020","unstructured":"Tan Q, Ng AL, Choy BN, Cheng GP, Woo VC, Cho P. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial. Ophthalmic Physiol Opt. 2020;40(5):557\u201366.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"4","key":"755_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.clae.2018.10.026","volume":"42","author":"Z Chen","year":"2019","unstructured":"Chen Z, Huang S, Zhou J, Xiaomei Q, Zhou X, Xue F. Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-a preliminary retrospective study. Cont Lens Anterior Eye. 2019;42(4):439\u201342.","journal-title":"Cont Lens Anterior Eye"},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1471-2415-14-141","volume":"14","author":"MJ Zhu","year":"2014","unstructured":"Zhu MJ, Feng HY, He XG, Zou HD, Zhu JF. The control effect of orthokeratology on axial length elongation in Chinese children with myopia. BMC Ophthalmol. 2014;14:141.","journal-title":"BMC Ophthalmol"},{"key":"755_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.853293","volume":"9","author":"T Cai","year":"2022","unstructured":"Cai T, Zhao L, Kong L, Du X. Complex Interplay Between COVID-19 Lockdown and Myopic Progression. Front Med (Lausanne). 2022;9: 853293.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"755_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10384-018-0608-3","volume":"62","author":"N Kinoshita","year":"2018","unstructured":"Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kakehashi A. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Jpn J Ophthalmol. 2018;62(5):544\u201353.","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"755_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10792-020-01658-0","volume":"41","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Hao Q. Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children. Int Ophthalmol. 2021;41(3):1011\u20137.","journal-title":"Int Ophthalmol"},{"issue":"5","key":"755_CR21","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1097\/OPX.0b013e31819fa5aa","volume":"86","author":"A Mathur","year":"2009","unstructured":"Mathur A, Atchison DA. Effect of orthokeratology on peripheral aberrations of the eye. Optom Vis Sci. 2009;86(5):E476\u201384.","journal-title":"Optom Vis Sci"},{"issue":"1","key":"755_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ophtha.2014.07.042","volume":"122","author":"T Hiraoka","year":"2015","unstructured":"Hiraoka T, Kakita T, Okamoto F, Oshika T. Influence of ocular wavefront aberrations on axial length elongation in myopic children treated with overnight orthokeratology. Ophthalmology. 2015;122(1):93\u2013100.","journal-title":"Ophthalmology"},{"issue":"3","key":"755_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/opo.12052","volume":"33","author":"NA McBrien","year":"2013","unstructured":"McBrien NA, Stell WK, Carr B. How does atropine exert its anti-myopia effects? Ophthalmic Physiol Opt. 2013;33(3):373\u20138.","journal-title":"Ophthalmic Physiol Opt"},{"key":"755_CR24","first-page":"1277","volume":"15","author":"VA Barathi","year":"2009","unstructured":"Barathi VA, Weon SR, Beuerman RW. Expression of muscarinic receptors in human and mouse sclera and their role in the regulation of scleral fibroblasts proliferation. Mol Vis. 2009;15:1277\u201393.","journal-title":"Mol Vis"},{"issue":"11","key":"755_CR25","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1097\/OPX.0b013e31826c1831","volume":"89","author":"Z Chen","year":"2012","unstructured":"Chen Z, Niu L, Xue F, et\u00a0al. Impact of pupil diameter on axial growth in orthokeratology. Optom Vis Sci. 2012;89(11):1636\u201340.","journal-title":"Optom Vis Sci"},{"key":"755_CR26","doi-asserted-by":"publisher","first-page":"4919154","DOI":"10.1155\/2020\/4919154","volume":"2020","author":"HY Sun","year":"2020","unstructured":"Sun HY, Lu WY, You JY, Kuo HY. Peripheral refraction in myopic children with and without atropine usage. J Ophthalmol. 2020;2020:4919154.","journal-title":"J Ophthalmol"},{"issue":"2","key":"755_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41433-021-01923-1","volume":"37","author":"J Tian","year":"2023","unstructured":"Tian J, Wei S, Li S, et\u00a0al. The effect of atropine 0.01% eyedrops on relative peripheral refraction in myopic children. Eye (Lond). 2023;37(2):356\u201361.","journal-title":"Eye (Lond)"},{"issue":"8","key":"755_CR28","first-page":"1069","volume":"106","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zhou J, Xue F, Qu X, Zhou X. Two-year add-on effect of using low concentration atropine in poor responders of orthokeratology in myopic children. Br J Ophthalmol. 2022;106(8):1069\u201372.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"755_CR29","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1167\/iovs.11-8453","volume":"53","author":"T Hiraoka","year":"2012","unstructured":"Hiraoka T, Kakita T, Okamoto F, Takahashi H, Oshika T. Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53(7):3913\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"755_CR30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/02713683.2015.1050743","volume":"41","author":"SM Li","year":"2016","unstructured":"Li SM, Kang MT, Wu SS, et\u00a0al. Efficacy, safety and acceptability of orthokeratology on slowing axial elongation in myopic children by meta-analysis. Curr Eye Res. 2016;41(5):600\u20138.","journal-title":"Curr Eye Res"},{"issue":"8","key":"755_CR31","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1167\/iovs.18-26247","volume":"60","author":"J Rozema","year":"2019","unstructured":"Rozema J, Dankert S, Iribarren R, Lanca C, Saw SM. Axial growth and lens power loss at myopia onset in singaporean children. Invest Ophthalmol Vis Sci. 2019;60(8):3091\u20139.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-023-00755-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-023-00755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T10:45:34Z","timestamp":1692614734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-023-00755-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1007\/s40123-023-00755-4","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"9 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}